Growth hormone preserves cardiac sarcoplasmic reticulum Ca2+ release channels (ryanodine receptors) and enhances cardiac function in cardiomyopathic hamsters

Cardiovascular Research

Volumn 40, Issue 1, 1998, Pages 64-73

  Ueyama, Takeshi ^a   Ohkusa, Tomoko ^a   Yano, Masafumi ^a   Matsuzaki, Masunori ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiomyopathic hamster; Growth hormone; Heart failure; Ryanodine receptor; Sarcoplasmic reticulum

Indexed keywords

CALCIUM; CALCIUM CHANNEL; RECOMBINANT GROWTH HORMONE; RYANODINE RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DRUG EFFECT; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE SIZE; HORMONE ACTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; SARCOPLASMIC RETICULUM;

ANIMALS; CARDIOMYOPATHY, DILATED; CRICETINAE; ECHOCARDIOGRAPHY; GROWTH HORMONE; HUMAN GROWTH HORMONE; MESOCRICETUS; MYOCARDIAL CONTRACTION; MYOCARDIUM; RYANODINE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM;

EID: 0032189994     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00095-9     Document Type: Article

References (43)

1. [1] Albinin CH, Sotos J, Sherman B, et al. Diagnostic significance of urinary growth hormone measurements in children with growth failure: correlation between serum and urine growth hormone. Pediatr Res 1991;29:619-622.
2. [2] Ambler GR, Johnston BM, Maxwell L, et al. Improvement of doxorubicin induced cardiomyopathy in rats treated with insulin-like growth factor 1. Cardiovasc Res 1993;27:1368-1373.
3. [3] Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
4. 31P-NMR study. Circulation, 1988;77:712-719.
5. [5] Cittadini A, Stromer H, Katz SE, et al. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat: a combined in vivo and in vitro evaluation. Circulation, 1996;93:800-809.
6. [6] DeGroot, L.J., Endocrinology, 2nd edition, Philadelphia: W.B.Saunders Company, 1989.
7. [7] Duerr RL, Huang S, Miraliakbar HR, et al. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 1995;95:619-627.
8. [8] Dusko J, Vogel JHK, Chidsey CA. Reduced calcium uptake and ATPase of the sarcoplasmic reticular fraction prepared from chronically failing calf hearts. Circ Res 1970;27:235-247.
9. [9] Fazio S, Sabatini D, Capaldo B, et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Eng J Med 1996;334:809-814.
10. [10] Feigenbaum, H., The echocardiographic examination. In: Echocardiography, edited by H. Feigenbaum. Philadelphia: Lea and Febuger, 1986: 50-104.
11. [11] Gilbert PL, Siegel RJ, Melmed S, et al. Cardiac morphology in rats with growth hormone-producing tumors. J Mol Cell Cardiol 1985;17:805-811.
12. [12] Heidenhaim M. Uber die Mallory'sche Binde-gewebstarbung mit Karmin und Azokarmin als Vorfarben. Z Wiss Mikrosk 1951;32:361-372.
13. [13] Hejtmancik MR, Bradfield JY, Herrmann GR. Acromegaly and the heart: a clinical and pathological study. Ann Intern Med 1951;34:1445-1446.
14. [14] Hjalmarson A, Isakasson O, Ahren K. Effects of growth hormone and insulin on amino acid transport in perfused rat heart. Am J Physiol 1969;217(6):1795-1802.
15. [15] Homburger F. Myopathy of hamster dystrophy: history and morphologic aspects. Ann NY Acad Sci 1979;317:2-17.
16. [16] Inoko M, Kihara Y, Morii I, et al. Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats. Am J Physiol 1994;267:H2471-2482.
17. [17] Inui M, Saito A, Fleischer S. Isolation of the ryanodine receptor from cardiac sarcoplasmic reticulum and identity with the feet structure. J Biol Chem 1987;262:15637-15642.
18. [18] Jasmin G, Proschek L. Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. I. Progression of heart and skeletal muscle lesions in the UM-X7. 1 line. Muscle and Nerve, 1982;5:20-25.
19. [19] Jasmin G, Proschek L. Calcium and myocardial cell injury: an appraisal in the cardiomyopathic hamster. Can J Physiol Pharmacol 1984;62:891-898.
20. [20] Lie JT, Grossman SJ. Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J 1980;100:41-52.
21. [21] Litwin SE, Katz SE, Morgan JP, et al. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation, 1994;89(1):345-354.
22. [22] Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-275.
23. [23] Mayoux E, Ventura-Clapier R, Timsit J, et al. Mechanical properties of rat cardiac skinned fibers are altered by chronic growth hormone hypersecretion. Circ Res 1993;72:57-64.
24. [24] Norgaard A, Baandrup U, Larsen JS, et al. Heart Na/K-ATPase activity in cardiomyopathic hamster as estimated from K-dependent 3-0-MPFase activity in crude homogenates. J Mol Cell Cardiol 1987;19:589-594.
25. [25] Ohkusa T, Hisamatsu Y, Yano M, et al. Altered cardiac mechanism and sarcoplasmic reticulum function in pressure overload-induced cardiac hypertrophy in rats. J Mol Cell Cardiol 1997;29:45-54.
26. [26] Panagia V, Singh JN, Anand-Srivastava MB, et al. Sarcolemmal alterations during the development of genetically determined cardiomyopathy. Cardiovasc Res 1984;18:567-572.
27. [27] Panagia V, Lee SL, Singh A, et al. Impairment of mitochondrial and sarcoplasmic reticulum functions during the development of heart failure in cardiomyopathic hamsters. Can J Cardiol 1986;2:234-247.
28. [28] Proschek L, Jasmin G. Hereditary polymyopathy and cardiomyopathy in the Syrian hamster. II. Development of heart necrotic change in relation to defective mitochondrial function. Muscle and Nerve, 1982;5:26-32.
29. [29] Sacca L, Cittadini A, Fazio S. Growth hormone and the heart. Endocr Rev 1994;15:555-573.
30. [30] Timsit J, Riou B, Bertherat J, et al. Effects of chronic growth hormone hypersecration on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle. J Clin Invest 1990;86:507-515.
31. [31] Timsit J, Mercadier JJ. Effects of chronic growth hormone excess on cardiac contractility and myosin phenotype in the rat. Acta Paediatr 1992;383:32-34.
32. [32] Tong J, Ganguly PK, Signal PK, et al. Myocardial adrenergic changes at two stages of heart failure due to adriamycin treatment in rats. Am J Physiol 1991;260:H909-H916.
33. [33] Uegaito T, Fujiwara M, Ishida M, et al. Hypertrophy of surviving myocates overlying the intact in human old myocardial infarctions with abnormal Q waves. Int J Cardiol 1991;32(1):93-101.
34. 2+-release channels (ryanodine receptors) during development of heart failure in cardiomyopathic hamsters. Am J Physiol 1998;274(43):H1-H7.
35. [35] van den Heuval PA, Elbers HR, Plokker HW, et al. Myocardial involvement in acromegaly. Int J Cardiol 1984;6:550-553.
36. [36] Vatner DE, Sato N, Kiuchi K, et al. Decrease in myocardial ryanodine receptors and altered excitation-contraction coupling early in the development of heart failure. Circulation, 1994;90:1423-1430.
37. [37] Weber KT, Janicki JS, Shroff SG, et al. Collagen remodeling of the pressure-overloaded, hypertrophied non-human primate myocardium. Circ Res 1988;62:757-765.
38. [38] Whitmer JT, Kumar P, Solaro RJ. Calcium transport properties of cardiac sarcoplasmic reticulum from cardiomyopathic Syrian hamsters (BIO53.58 and BIO 14.6): evidence for a quantitative defect in dilated myopathic hearts not evident in hypertrophic hearts. Circ Res 1988;62:81-85.
39. [39] Wikman-Coffelt, J., Sievers, R., Coffelt, R.J. et al. Biochemical and mechanical correlates at peak systole in myopathic, Syrian hamster. In Jacob RJ (ed): Cardiac Adaptation to Hemodynamic Overload, Training and Stress. Tubingen, FRG: Steinkopff-Verlag, 1983: 197-203.
40. [40] Wikman-Coffelt J, Sievers R, Parmley WW. Cardiomyopathic and healthy acidotic hamster hearts: mitochondrial activity may regulate cardiac performance. Cardiovasc Res 1986;20:471-481.
41. + current in ventricular myocytes from acromegalic rats. Am J Physiol 1991;260:H935-H942.
42. [42] Yang R, Bunting S, Gillett N, et al. Growth hormone improves cardiac performance in experimental heart failure. Circulation, 1995;92:262-267.
43. 2+ channels: a possible mechanism of ischemic preconditioning. Circ Res 1995;76:1049-1056.